Inpixon: Könnte da bald was kommen? (Seite 13)
eröffnet am 29.11.17 14:09:28 von
neuester Beitrag 07.08.23 20:05:22 von
neuester Beitrag 07.08.23 20:05:22 von
Beiträge: 143
ID: 1.268.342
ID: 1.268.342
Aufrufe heute: 0
Gesamt: 13.642
Gesamt: 13.642
Aktive User: 0
ISIN: US98423K1088 · WKN: A3EYDX · Symbol: XTIA
0,9375
USD
-11,56 %
-0,1225 USD
Letzter Kurs 02:00:00 Nasdaq
Neuigkeiten
| TitelBeiträge |
|---|
23.10.23 · Business Wire (engl.)  |
28.07.23 · Business Wire (engl.) |
26.07.23 · Business Wire (engl.) |
Werte aus der Branche Luftfahrt und Raumfahrt
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 0,5780 | +40,98 | |
| 21,300 | +14,27 | |
| 25,51 | +10,77 | |
| 29.298,00 | +10,45 | |
| 7,9000 | +5,33 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 4,0700 | -8,33 | |
| 0,9300 | -11,43 | |
| 0,9375 | -11,56 | |
| 13,260 | -11,60 | |
| 3,8000 | -14,80 |
Beitrag zu dieser Diskussion schreiben
Feedback
Guten Morgen,
also ich bin seit gestern auch dabei, handle aber über US.
War gestern mal auf der Seite und bin überrascht, wie vielfältig die Anwendungen sein können. Blockchain ist hier natürlich nicht mit irgendeiner Währung in Verbindung zu bringen sondern von Standardisierung im Sicherheits- und Shoppingbereich zu verstehen. Aber die Technik überzeugt mich und werde das Unternehmen eine Weile begleiten.
Viele Grüße und maximale Erfolge
also ich bin seit gestern auch dabei, handle aber über US.
War gestern mal auf der Seite und bin überrascht, wie vielfältig die Anwendungen sein können. Blockchain ist hier natürlich nicht mit irgendeiner Währung in Verbindung zu bringen sondern von Standardisierung im Sicherheits- und Shoppingbereich zu verstehen. Aber die Technik überzeugt mich und werde das Unternehmen eine Weile begleiten.
Viele Grüße und maximale Erfolge
Nach der News gestern hätte ich erwartet, das wir die 0,40 nachhaltig knacken, von der Bewertung her sollte noch so einiges gehen.
Antwort auf Beitrag Nr.: 56.673.755 von superkarl1 am 10.01.18 14:23:57Daumen hoch!
Bin mal gespannt wie es weiter geht
Bin mal gespannt wie es weiter geht
Antwort auf Beitrag Nr.: 56.667.452 von Timepassengers am 09.01.18 22:00:56Vorbörslich sieht es ja schon mal gut aus, was aber nichts heißen muss
Morgen über Stuttgart 21 :
0,50€
0,50€
Trading Spotlight
__INPIXON__ mobile device & big data (IoT)
Lassen wir es morgen krachen
Lassen wir es morgen krachen
ERST EINSTIEG vorhin
0,2751 USD
Ziel 1 USD
Prima
0,2751 USD
Ziel 1 USD
Prima
https://www.sec.gov/Archives/edgar/data/1529113/000121390018…
Item 1.01 Entry into a Material Definitive Agreement
Purchase Agreement, Warrant and Placement Agency Agreement
On January 5, 2018, Inpixon (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain investors (the “Investors”) pursuant to which the Company agreed to sell, in a registered direct offering, an aggregate of 17,994,359 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), at a purchase price of $0.177 per share.
Concurrently with the sale of the Shares, pursuant to the Purchase Agreement the Company also agreed to sell warrants to purchase up to 17,994,359 shares (the “Warrant Shares”) of Common Stock (the “Warrants”). The aggregate gross proceeds for the sale of the Shares and Warrants will be approximately $3.2 million. The Warrants will be exercisable beginning on or after the later of (i) the date on which the Company’s files an amendment to its articles of incorporation (the “Amendment”), approved by its stockholders, to increase the number of authorized shares of the Company’s common stock such that all of the Warrants may be exercised in full by the holders of the Warrants and (ii) the date on which the Shareholder Approval (as defined below) is obtained and deemed effective (the “Initial Exercise Date”), at an exercise price per share equal to $0.22, subject to certain adjustments pursuant to the terms of the Warrants (the “Exercise Price”), and will expire on the five year anniversary of the Initial Exercise Date.
The closing of the sales of these securities under the Purchase Agreement occurred on January 8, 2018.
The Warrants provide for adjustment of the Exercise Price if, while the Warrants are outstanding, the Company or any significant subsidiary thereof, as applicable, shall sell or grant any option to purchase, or sell or grant any right to reprice, or otherwise dispose of or issue (or announce any offer, sale, grant or any option to purchase or other disposition) any Common Stock or Common Stock equivalents, at an effective price per share that is less than the Exercise Price then in effect (such lower price, the “Base Share Price” and such issuances collectively, a “Dilutive Issuance”). In the event a Dilutive Issuance occurs, the Exercise Price shall be reduced and only reduced to equal the Base Share Price, provided that the Base Share Price shall not be less than $0.10 (subject to adjustment for reverse and forward stock splits, recapitalizations and similar transactions following the date of the Purchase Agreement).
Pursuant to the terms of the Purchase Agreement and the Warrant, the Company agreed to hold an annual or special meeting of stockholders on or prior to February 15, 2018 for the purpose of obtaining the approval of the Company’s stockholders of the Amendment (the “Authorized Share Approval”) and such approval as may be required by the applicable rules and regulations of the Nasdaq Stock Market (or any successor entity) from the stockholders of the Company, including the issuance of all of the Warrant Shares, in accordance with NASDAQ Rule 5635(d) (the “Shareholder Approval”, together with the Authorized Share Approval, the “Required Approvals”). If the Company does not obtain the Required Approvals at the first meeting, the Company has agreed to call a meeting every forty-five (45) days thereafter to seek Authorized Share Approval and Shareholder Approval until the earlier of the date on which Authorized Share Approval and Shareholder Approval are obtained or the Warrants are no longer outstanding. In addition, subject to certain exempt issuances, until the Required Approvals are received, the Company may not issue any shares of Common Stock or common stock equivalents.
Until the 12 month anniversary of the date on which the Company obtains the Shareholder Approval, investors that purchase Shares in the offering have the right to participate in any financing of the Company through the sale of its common stock or common stock equivalents for cash consideration, indebtedness or a combination of cash or indebtedness, up to an amount equal to 30% of such financing.
Each of the Purchasers and the Company also entered into a leak-out agreement (the “Leak-out Agreement”) pursuant to which the Purchasers agreed that on January 9, 2018, the Purchasers would not sell, dispose or otherwise transfer, directly or indirectly, any Shares in an amount equal to such Purchaser’s pro rata portion of 35% of the trading volume of the Company’s Common Stock as reported by Bloomberg, LP for such date.
Roth Capital Partners, LLC acted as the exclusive placement agent (the “Placement Agent”) for the Company, on a “reasonable best efforts” basis, in connection with the offering. Pursuant to that certain Placement Agency Agreement, dated as of January 5, 2018, by and between the Company and the Placement Agent (the “Placement Agency Agreement”), the Placement Agent will be entitled to a cash fee of 8.0% of the aggregate gross proceeds of the offering for the securities and reimbursement of certain out-of-pocket expenses up to an aggregate of $80,000.
Item 1.01 Entry into a Material Definitive Agreement
Purchase Agreement, Warrant and Placement Agency Agreement
On January 5, 2018, Inpixon (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain investors (the “Investors”) pursuant to which the Company agreed to sell, in a registered direct offering, an aggregate of 17,994,359 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), at a purchase price of $0.177 per share.
Concurrently with the sale of the Shares, pursuant to the Purchase Agreement the Company also agreed to sell warrants to purchase up to 17,994,359 shares (the “Warrant Shares”) of Common Stock (the “Warrants”). The aggregate gross proceeds for the sale of the Shares and Warrants will be approximately $3.2 million. The Warrants will be exercisable beginning on or after the later of (i) the date on which the Company’s files an amendment to its articles of incorporation (the “Amendment”), approved by its stockholders, to increase the number of authorized shares of the Company’s common stock such that all of the Warrants may be exercised in full by the holders of the Warrants and (ii) the date on which the Shareholder Approval (as defined below) is obtained and deemed effective (the “Initial Exercise Date”), at an exercise price per share equal to $0.22, subject to certain adjustments pursuant to the terms of the Warrants (the “Exercise Price”), and will expire on the five year anniversary of the Initial Exercise Date.
The closing of the sales of these securities under the Purchase Agreement occurred on January 8, 2018.
The Warrants provide for adjustment of the Exercise Price if, while the Warrants are outstanding, the Company or any significant subsidiary thereof, as applicable, shall sell or grant any option to purchase, or sell or grant any right to reprice, or otherwise dispose of or issue (or announce any offer, sale, grant or any option to purchase or other disposition) any Common Stock or Common Stock equivalents, at an effective price per share that is less than the Exercise Price then in effect (such lower price, the “Base Share Price” and such issuances collectively, a “Dilutive Issuance”). In the event a Dilutive Issuance occurs, the Exercise Price shall be reduced and only reduced to equal the Base Share Price, provided that the Base Share Price shall not be less than $0.10 (subject to adjustment for reverse and forward stock splits, recapitalizations and similar transactions following the date of the Purchase Agreement).
Pursuant to the terms of the Purchase Agreement and the Warrant, the Company agreed to hold an annual or special meeting of stockholders on or prior to February 15, 2018 for the purpose of obtaining the approval of the Company’s stockholders of the Amendment (the “Authorized Share Approval”) and such approval as may be required by the applicable rules and regulations of the Nasdaq Stock Market (or any successor entity) from the stockholders of the Company, including the issuance of all of the Warrant Shares, in accordance with NASDAQ Rule 5635(d) (the “Shareholder Approval”, together with the Authorized Share Approval, the “Required Approvals”). If the Company does not obtain the Required Approvals at the first meeting, the Company has agreed to call a meeting every forty-five (45) days thereafter to seek Authorized Share Approval and Shareholder Approval until the earlier of the date on which Authorized Share Approval and Shareholder Approval are obtained or the Warrants are no longer outstanding. In addition, subject to certain exempt issuances, until the Required Approvals are received, the Company may not issue any shares of Common Stock or common stock equivalents.
Until the 12 month anniversary of the date on which the Company obtains the Shareholder Approval, investors that purchase Shares in the offering have the right to participate in any financing of the Company through the sale of its common stock or common stock equivalents for cash consideration, indebtedness or a combination of cash or indebtedness, up to an amount equal to 30% of such financing.
Each of the Purchasers and the Company also entered into a leak-out agreement (the “Leak-out Agreement”) pursuant to which the Purchasers agreed that on January 9, 2018, the Purchasers would not sell, dispose or otherwise transfer, directly or indirectly, any Shares in an amount equal to such Purchaser’s pro rata portion of 35% of the trading volume of the Company’s Common Stock as reported by Bloomberg, LP for such date.
Roth Capital Partners, LLC acted as the exclusive placement agent (the “Placement Agent”) for the Company, on a “reasonable best efforts” basis, in connection with the offering. Pursuant to that certain Placement Agency Agreement, dated as of January 5, 2018, by and between the Company and the Placement Agent (the “Placement Agency Agreement”), the Placement Agent will be entitled to a cash fee of 8.0% of the aggregate gross proceeds of the offering for the securities and reimbursement of certain out-of-pocket expenses up to an aggregate of $80,000.
Durchsuchen
